Cepodem 40 mg/5 ml, 100 mg / 200 mg, Film-coated tablets, Powder for Oral Suspension
PDF Leaflet Revision Date: 26 September 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Short-term treatment of upper and lower respiratory tract infections.
Dosage (summary)
Adults: 100 mg every 12 hours for mild infections; 200 mg every 12 hours for severe infections. Children: 8 mg/kg/day in two doses.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Safety in pregnancy and lactation not established.
Key Drug Interactions
- Antacids decrease absorption
- Probenecid reduces renal excretion
- Enhances warfarin effect
Contraindications
- Hypersensitivity to cefpodoxime
- Children under 1 year
- Pregnancy and lactation
Common side effects
- Nausea
- Vomiting
- Abdominal pain
- Diarrhea
- Eosinophilia
Counselling Points
- Take with meals
- Shake suspension before use
- Report severe diarrhea immediately
Serious warnings
- Anaphylactic reactions possible
- Pseudomembranous colitis risk
- Monitor renal function
Important Disclaimer
The Cepodem 40 mg/5 ml, 100 mg / 200 mg, Film-coated tablets, Powder for Oral Suspension professional information leaflet below is the property of Ranbaxy Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
